In 1989, molecular biology development led to the discovery of the CFTR (Cystic Fibrosis Transmembrane Regulator) gene and also rapidly to the first report of a variation, F508del, which is now identified in 70% of people with CF (pwCF) [5,6,7,8]. This evidence concerns the gene CFTR and cystic fibrosis.